| Unique ID issued by UMIN | UMIN000055863 |
|---|---|
| Receipt number | R000063845 |
| Scientific Title | Assessment of the impact of menstruation-related symptoms on daily life through wearable terminals and questionnaires. |
| Date of disclosure of the study information | 2024/10/21 |
| Last modified on | 2025/04/02 10:07:23 |
Assessment of the impact of menstruation-related symptoms on daily life through wearable terminals and questionnaires.
Assessment of the impact of menstruation-related symptoms on daily life through wearable terminals and questionnaires.
Assessment of the impact of menstruation-related symptoms on daily life through wearable terminals and questionnaires.
Assessment of the impact of menstruation-related symptoms on daily life through wearable terminals and questionnaires.
| Japan |
Adult woman
| Obstetrics and Gynecology | Adult |
Others
NO
Examine the possibility of quantifying the impact of menstruation-related symptoms on daily life using biometric data acquired from wearable devices.
Others
Quantifying the impact of menstruation-related symptoms on daily life using biometric data
Exploratory
Others
Not applicable
Explore wearable device data in relation to MDQ scores
(1)Explore wearable device data associated with QOL questionnaire scores
(2)Relationship between physical condition records and MDQ scores in apps
Observational
| 18 | years-old | <= |
| 49 | years-old | >= |
Female
(1)Premenopausal women between the ages of 18 and 49 at the time consent is obtained
(2)Those whose menstrual cycles can be confirmed
(3)Those who regularly record menstrual information in a health care application
(4)Own a smartphone device on which the wearable device application can be installed, and agree to the terms of use for the wearable device and application used in the study.
(5)Those who have given appropriate written consent to participate in this study.
(1)Who have an infectious disease or a disease under treatment that makes it difficult for them to manage their health
(2)Patients who have been taking estrogen/progestin, progestin, or GnRH analogs within 2 months of the start of the study
(3)Who have not had a menstrual period for more than 3 months, are pregnant, or are lactating
(4)Who are using devices or medications that can affect the heartbeat, such as pacemakers or drugs
(5)Those with eczema, allergies, asthma, sensitive skin, or other conditions that could easily cause dermatitis due to wearable devices
(6)Any other person who is deemed by the principal investigator to be inappropriate to participate in this study.
500
| 1st name | Kazumichi |
| Middle name | |
| Last name | Minato |
TechDoctor, Inc.
Board Member
104-0031
2-2-1 Kyobashi, Chuo-ku, Tokyo
03-5476-8889
minato@technology-doctor.com
| 1st name | Kosaku |
| Middle name | |
| Last name | Kawada |
TechDoctor, Inc.
Business Development
104-0031
2-2-1 Kyobashi, Chuo-ku, Tokyo
03-5476-8889
kawada@technology-doctor.com
TechDoctor, Inc.
ASKA Pharmaceutical Co., Ltd.
Profit organization
ASKA Pharmaceutical Co., Ltd.
Yoyogi Mental Clinic Research Ethics Committee
4-26-11 Sendagaya, Shibuya-ku, Tokyo
03-6804-2227
cns_jimu(a)triad-j.co.jp
NO
| 2024 | Year | 10 | Month | 21 | Day |
Unpublished
Completed
| 2024 | Year | 09 | Month | 27 | Day |
| 2024 | Year | 10 | Month | 07 | Day |
| 2024 | Year | 10 | Month | 21 | Day |
| 2025 | Year | 01 | Month | 31 | Day |
| 2025 | Year | 02 | Month | 28 | Day |
| 2025 | Year | 02 | Month | 28 | Day |
| 2025 | Year | 09 | Month | 30 | Day |
Quantifying the impact of menstruation-related symptoms on daily life using biometric data
| 2024 | Year | 10 | Month | 17 | Day |
| 2025 | Year | 04 | Month | 02 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000063845